Cell No. : Cell Name
RCB5691 : ATG2A/B double KO MEF
update : 2023/12/01
|
| Comment | Currently not ready. |
| Comment from the depositor | Mouse embryonic fibroblast in which Atg2A/B genes were deleted using CRISPR/Cas9-mediated genome editing. |
| Terms and conditions | |
| Remarks | CRISPR/Cas9 genome edited bioresources Announcement of bioresources developed by the CRISPR/Cas9 technology. |
| Order Form |
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
|
Basic information
|
Expected time |
Upon a request we will start preparation. Contact us: cellkitaku.brc@riken.jp
|
| Reference information |
Reference |
1
|
| User's Publication |
0
|
Back
Top
CELL BANK Website